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A B S T R A C T
Gastric cancer is very common malignant disease, etiology of which is still unknown.
Some studies consider that it is caused by a joint activity of both genetic and environ-
mental factors. Digito-palmar dermatoglyphs were already used to determine heredi-
tary base of some malignant diseases (breast, lung and colorectal cancer) and it was the
reason for investigations of the correlation of their quantity features at patients with
gastric cancer (36 males and 32 females) and the control groups of phenotypically
healthy persons (50 males and 50 females). By performing statistical data processing of
the multivariate and univariate analysis, as well as of discriminant ones, it was possi-
ble to prove the existence of heterogeneity between the investigated groups. Higher inci-
dence of gastric cancer and the blood group A could be confirmed, as well. From the ob-
tained findings can be concluded, that the results of quantitative analysis of digito-
palmar dermatoglyphs affirm the existence of genetic predisposition for development of
gastric cancer.
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Introduction
Gastric cancer is rather common ma-
lignancy in general and the most common
malignancy of the alimentary bowel, al-
though its incidence has been falling dur-
ing the last 50 years1. This disease has
some very interesting epidemiological cha-
racteristics. The incidence varies through-
out the world, but there are also high-in-
cidence and low-incidence areas within
the same country. Japan has the highest
incidence (78/100,000), and the USA has
the lowest one (6/100,000)2. Croatia is
considered to be one of the high-incidence
countries, where gastric cancer takes the
second place in male (25/100,000) and the
third one in female (11/100,000) popula-
tion. The northern parts of the country
have higher incidence than the southern
ones3,4.
Patho-histologically, 90–95% of gastric
cancers are adenocarcinomas, located
mostly in the antro-pylorical region (50–
60%)5. There are many classifications of
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this disease, but prognostically the most
important one divides it into the early-
type, limited to the upper layers, mucosis
and submucosis, and the advanced-type,
that has penetrated the muscularis pro-
pria and beyond6,7. Those two types sig-
nificantly differ in prognosis – the five-
year survival rate for early-type of gastric
cancer8 is 93–95% and for the advan-
ced-type is 5–15%. It is considered that it
takes eight years for early-type to become
advanced one, but because of the nonspe-
cific symptomatology, gastric cancer in
this early stage can be very rarely diag-
nosed, only 10% in the USA and 35% in
Japan9.
The etiology of gastric cancer, as well
as the etiology of other malignant dis-
eases still remains unclear, but both ge-
netic and environmental factors seem to
be important10,11. Gastric cancer is a fam-
ily disease in about 10% of the cases,
where the incidence between relatives is
almost four times higher12–14. In 25% of
the cases of heritable gastric cancer, trun-
cating mutations in the E-cadherin gene
(CDH1) are identified as predisposing
factors. This mutation is inherited as an
autosomal dominant trait with 60–80%
penetrance. In those cases the disease
usually appears before the age of 30 and
has bad prognosis15. The important role
in gastric carcinogenesis seem to have
the accumulation of c-myc16, bcl-217,18, c-
K-ras19 and p-5320,21 mutations22 as well
as the loss of allele23.
On the other side, the study of gastric
cancer incidence among Japanese immi-
grants to the USA points out the role of
the environmental factors. The incidence
in the first generation was the same as
the one in Japan, but it decreased in the
second one and in the third one it was al-
ready the same as in the USA. It means
that some environmental factors in Ja-
pan are not present in the USA. The most
important environmental factor is food,
containing a carcinogen or being conver-
ted into one either during preparation and
preservation or in the stomach after in-
gestion24,25. Established carcinogens are
nitrozamines26,27. Some importance show
also 3,4-benzopyrene, salt, alcohol and
smoking28–30, while vitamins C, A, E, or-
ganosulphoric compounds in onion, fito-
chemicyns, flavonoids in tea and cereal fi-
ber seem to have protective role31,32.
The Helicobacter pylori is also es-
tablished carcinogen and this infection
increases about 5 times the risk of can-
-cer 33–35.
The incidence of the blood group A
among gastric cancer patients seems to
be the most common one2.
Dermatoglyphs are patterns made by
epidermis on fingers, palms and soles.
They are completely formed by 21st week
of the intrauterine development and fur-
thermore, totally resistant to any exter-
nal factor, remaining unchanged until the
end of a person’s life. These are highly he-
reditary characteristics, although the ex-
act way of inheritance is still unknown
and strongly individual, because there
are not two persons in the world with the
same dermatoglyphics36–37. Therefore,
studying of dermatoglyphs contributes to
our better understanding of genetic sta-
tus and early intrauterine development
and it makes them applicable in biomedi-
cal sciences38.
The aim of this study is to test the hy-
pothesis of genetic predisposition for gas-
tric cancer. The necessary for the develop-
ment of the gastrointestinal tract and for
development of the dermatoglyphs is the
same and the disturbances in embryo-
logical life could have influences on devel-
opment of the cancer, but they could also
have reflection on dermatoglyphic pat-
terns. This reflection can be tested using
the comparative analysis of dermato-
glyphs of the digito-palmar complex in
groups of gastric cancer patients and the
healthy controls.
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Materials and Methods
We investigated digito-palmar derma-
toglyphs of 68 patients (36 male and 32
female), who have had patho-histological
diagnosis »adenocarcinoma ventriculi«.
Comparative group was made of 100 phe-
notypically healthy inhabitants of the town
of Sisak (50 males and 50 females) who
have never had any malignant disease.
The digito-palmar prints were taken and
analyzed according to the Cummins and
Midlo39 methods, and some pieces of ad-
vice were taken from the book Mili~i} et
al.40.
The analysis comprised a total of 18
quantitative variables of digito-palmar
dermatoglyphics (finger ridge-counts on
the right and the left hand: FRR1, FRR2,
FRR3, FRR4, FRR5, FRL1, FRL2, FRL3,
FRL4, FRL5; palmar ridge-counts on the
right and on the left hand: a-b rc R, b-c rc
R, c-d rc R, a-b rc L, b-c rc L, c-d rc L and
the atd angles (atdR and atdL). The
quantitative traits of digito-palmar der-
matoglyphs were analyzed by using de-
scriptive statistics, multivariate and uni-
variate variance analysis and discrimi-
nant analysis.
Results
The results of descriptive statistics
comparing 18 quantitative variables of
digito-palmar dermatoglyphs from gas-
tric cancer patient groups (male and fe-
male) and their control groups are pre-
sented on Table 1 in males and Table 2 in
females.
Multivariate analysis of variance (Ta-
ble 3) enabled throwing off the hypothesis
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TABLE 1
DESCRIPTIVE STATISTICS FOR QUANTITATIVE DIGITO-PALMAR DERMATOGLYPHIC TRAITS IN
THE GROUP OF MALE PATIENTS SUFFERING FROM GASTRIC CANCER (N = 36) AND HEALTHY
CONTROL MALES (N = 50)
Gastric cancer Healthy control
Variables X SD X SD
FRR 1 19.44 6.05 18.92 4.89
FRR 2 12.50 7.19 12.32 6.17
FRR 3 14.08 7.01 12.10 5.07
FRR 4 16.89 4.84 14.94 5.92
FRR 5 14.31 4.57 13.48 4.76
a-b rc R 35.20 5.25 38.82 6.03
b-c rc R 23.09 4.78 25.48 4.93
c-d rc R 31.57 5.19 35.22 6.52
atd R 40.91 5.72 42.76 5.90
FRL 1 17.19 5.92 16.12 4.78
FRL 2 12.22 5.77 10.80 5.95
FRL 3 14.06 7.01 12.34 4.74
FRL 4 16.83 5.70 14.94 4.57
FRL 5 13.53 3.99 12.62 4.78
a-b rc L 35.40 5.60 39.32 6.35
b-c rc L 23.83 3.84 25.02 5.53
c-d rc L 30.14 5.73 33.90 5.18
atd L 40.00 4.52 43.10 5.75
of homogeneity of investigated variables
between the groups we studied with p<
0.045 in males and p<0.046 in females.
The univariate analysis of variance en-
abled the identification of variables, mak-
ing the greatest contribution to this hete-
rogeneity between the investigated groups:
in males: a-b rc R (p<0.005), b-c rc R
(p<0.05), c-d rc R (p<0.01), a-b rc L (p<
0.005), c-d rc L (p<0.005) and atd L (p<
0.01) and in females: a-b rc R (p<0.005),
b-c rc R (p<0.005), c-d rc R (p<0.05) and
b-c rc L (p<0.005).
We also analyzed the differences be-
tween investigated groups using canoni-
cal discriminant analysis (Table 4). The
canonical discriminant analysis provided
correct classification in 76.5% of male
examinees (74.3% with gastric cancer and
78% healthy controls), while in females
76.8% examinees were correctly classified
(78.1% with gastric cancer and 76% healthy
controls).
We have also confirmed the statement
that gastric cancer is 1.2 times more often
in blood group A, than in blood group 02.
From 62 examinees that checked their
blood group, 23 had blood-group A and 19
had blood group 0 (23/19 = 1.2). This cor-
relation in healthy persons was different.
From 75 examinees with known blood-
group 26 blood-group A and 35 of them
had blood-group 0 (26/35 = 0.74).
Discussion
Gastric cancer is common malignancy
in general and the most common malig-
nancy of the alimentary bowel. Despite of
the fall of the incidence in the last 50
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TABLE 2
DESCRIPTIVE STATISTICS FOR QUANTITATIVE DIGITO-PALMAR DERMATOGLYPHIC TRAITS IN
THE GROUP OF FEMALE PATIENTS SUFFERING FROM GASTRIC CANCER (N = 32) AND HEALTHY
CONTROL FEMALES (N = 50)
Gastric cancer Healthy control
Variables X SD X SD
FRR 1 16.19 6.76 17.22 4.85
FRR 2 9.84 6.84 11.42 5.54
FRR 3 11.66 6.67 11.34 4.98
FRR 4 16.06 5.99 14.68 5.36
FRR 5 12.19 5.65 12.30 5.31
a-b rc R 34.06 5.07 36.58 5.54
b-c rc R 21.59 4.12 24.72 4.67
c-d rc R 30.88 5.37 33.96 6.12
atd R 41.78 6.36 44.22 8.19
FRL 1 13.81 5.28 14.64 4.80
FRL 2 9.16 6.52 10.20 5.90
FRL 3 10.94 6.89 12.16 5.25
FRL 4 14.38 7.09 14.36 4.65
FRL 5 11.44 5.84 11.82 4.88
a-b rc L 35.97 5.94 37.90 5.08
b-c rc L 20.47 4.53 24.44 4.97
c-d rc L 29.84 3.91 32.40 7.19
atd L 44.69 6.98 43.88 7.08
years, it is still a great medical problem
and frequent cause of death throughout
the world. Croatia is considered to be one
of the high-incidence countries where gas-
tric cancer takes a second place in male
and a third in female population groups.
The etiology of gastric cancer still re-
mains unclear, but both the environmen-
tal and the genetic factors seem to be im-
portant. Diet and Helicobacter pylori
infection are considered to be the most
important among the environmental fac-
tors. The genetic factors are the issue of
many investigations.
Many authors successfully applied der-
matoglyphics of digito-palmar complex to
estimate the hereditary base of some com-
mon malignant diseases: Basauri et al.40
and Croat authors Rudan et al.41 Mili~i}
et al.42 studied quantitative traits of breast
cancer, leiomyomas and fibromyomas ute-
ri, cervical cancer, colorectal cancer and
cancer of the thyroid gland, Mili~i} et
Pavi}evi}43 examined dermatoglyphics of
digito-palmar complex in four types of
bronchopulmonary carcinoma. All the au-
thors found differences, especially in pal-
mar dermatoglyphics, between the group
of patients suffering from different type
of carcinomas and healthy control groups.
They concluded, that gene instability
could be the basis for developing cancer
late in life by the influence of environ-
mental factors.
These studies encouraged us to inves-
tigate the quantitative traits in patients
with gastric cancer and the control group
of phenotypically healthy persons. Our
results show statistically significant het-
erogeneity between the gastric cancer
group and the control group at p<0.045 in
males and p<0.046 in females. The uni-
variate analysis of variance showed that
palmar ridge counts were significantly
lower in both sexes, while the canonical
discriminant analysis showed the correct
classification of 76.5% male and 76.8% fe-
male examinees, which was very high
percentages.
Our results harmonize with the re-
sults of other studies of quantitative traits
of digito-palmar dermatoglyphics of breast,
cervical, bronchopulmonary and colorec-
tal cancer. These studies also confirm the
existence of heterogeneity between the
examined groups, mostly as a result of
palmar dermatoglyphic characteristics.
With our study, we could prove that quan-
titative traits of digito-palmar dermato-
glyphs separate the group of patients
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TABLE 3
MULTIVARIATE AND UNIVARIATE ANALYSES
OF VARIANCE FOR THE QUANTITATIVE
DIGITO-PALMAR DERMATOGLYPHIC TRAITS
BETWEEN PATIENTS SUFFERING FROM
GASTRIC CANCER AND HEALTHY CONTROL
MALES AND FEMALES
Multivariate analysis
Male F = 0.656 df = 18 p<0.045
Female F = 0.661 df = 18 p<0.046
Univariate analysis (F)
Variables Males Females
FRR 1 0.109 0.648
FRR 2 0.005 1.311
FRR 3 2.196 0.061
FRR 4 2.404 1.184
FRR 5 0.899 0.008
a-b rc R 8.236*** 4.294***
b-c rc R 4.975* 9.560***
c-d rc R 7.590** 5.439*
atd R 2.069 2.044
FRL 1 0.611 0.536
FRL 2 0.982 0.563
FRL 3 1.849 0.827
FRL 4 2.904 0.001
FRL 5 0.756 0.103
a-b rc L 8.623*** 2.468
b-c rc L 1.214 13.319***
c-d rc L 9.932*** 3.395
atd L 7.083** 0.256
* p<0.05 ** p<0.01*** p<0.005
with gastric cancer from the control
group of phenotypically healthy persons
and therefore we can confirm the exis-
tence of genetic predisposition to gastric
cancer.
Acknowledgment
The Ministry of Science and Technol-
ogy of Republic of Croatia through Pro-
ject: 0196001 sponsored this work.
R E F E R E N C E S
1. ALEXANDER, H. R., P. D. KESLEN, J. E.
TEPPER, Cancer of the stomach. In: Principles and
practice of oncology. (Lippincot Co, Philadelphia,
1993). — 2. MAYER, R. J., Neoplasms of oesophagus
and stomach. In: Harrison's principles of medicine.
(McGraw-Hill, New York, 1994). — 3. BABU[, V.:
Epidemiologija. (Medicinska naklada, Zagreb, 1997).
— 4. STRNAD, M., Libri Oncol., 23 (1994) 91. — 5.
COTRAN, R., V. KUMAR, S. ROBBINS: Pathologic
basis of disease. (Saunders Company, Philadelphia,
1989). — 6. XIN, Y., F. ZHAO, W. GONG, Y. WANG, Y.
ZHANG, R. YAN, Chin. Med. Sci. J., 9 (1994) 119. —
7. MORI, M., Y. ADACHI, Y. KAKEJI, D. KORENA-
GA, K. SUGIMACHI, M. MOTOOKA, T. OIWA, Can-
cer, 69 (1992) 306. — 8. KODAMA, Y., K. INOKUCHI,
K. SOEJIMA, T. MATSUSAKA, T. OKAMURA, Can-
cer, 51 (1983) 320. — 9. VRDOLJAK, M., Med.
Jadert., 24 (1994) 1. — 10. KIM, J. H., N. G. KIM, Y.
G. LIM, C. PARK, H. KIM, Am. J. Pathol., 158 (2001)
655. — 11. CORREA, P.: Cancer Res., 52 (1992) 6735.
— 12. BAKIR, T., G. CAN, S. ERKUL, C. SIVILO-
GLU, Eur. J. Cancer Prev., 9 (2000) 401. — 12. KA-
KIUCHI, H.: Tumor Biol., 20 (1999) 235. — 13. CAL-
DAS, C., J. Med. Genet., 36 (1999) 873. — 14. HUNT-
SMAN, D. G., N. Engl. J. Med., 344 (2001) 1904. —
15. CARVALHO, F., Ann. Hum. Genet., 63 (1999) 187.
— 16. BRONNER, M. P., C. CULIN, J. C. REED, E. E.
FURTH, Am. J. Pathol., 146 (1995) 20. — 17. LAU-
WERS, G. Y., G. V. SCOTT, M. S. KARPEH, Cancer,
75 (1995) 2209. — 18. STRUL, H., N. ARBER, J. Ga-
stroenterol., 3 (2001) 1. — 19. OIWA, H., Y. MAEHA-
RA, S. OHNO, Y. SAKAGUCHI, Y. ICHIYOSHI, I.
SUGIMACHI, Cancer, 75 (1995) 1454. — 20. GAB-
BERT, H. E., W. MULLER, A. SCHNEDERS, S.
MEIER, G. HOMMEL, Cancer, 76 (1995) 720. — 21.
YASUI, W., H. YOKOZAKI, S. FUJIMOTO, K. NA-
KA, H. KUNIYASU, E. TAHARA, J. Gastroenterol.,
35 (2000) 111. — 22. CHUNG, Y. J., J. R. CHOI, S. W.
PARK, K. M. KIM, M. G. RHYN, Virchows Archiv-
Int. J. Pathol., 438 (2001) 31. — 23. GONZALES, C.
A., E. RIBOLI, J. BADOSA, E. BATISTE, T. CARDO-
NA, S. PITA, J. M. SANZ, M. TORRENT, A. AGUDO,
Am. J. Epidemiol., 139 (1994) 466. — 24. LA VE-
CCHIA, C., M. FERRARRINI, B. AVANZO, A. DE-
CARLI, S. FRANCESCHI, Cancer Epidemiol. Bio-
markers Prev., 3 (1994) 393. — 25. BARTSH, H. N.,
IARC Sci. publ., 105 (1991) 1. — 26. ROGERS, M. A.,
T. L. VAUGHAN, S. DAVIS, D. B. THOMAS, Cancer
Epidemiol. Biomarkers Prev., 4 (1995) 29. — 27. VAU-
GHAN, T. L., A. DAVIS, A. KRISTAL, D. B. THO-
MAS, Cancer Epidemiol. Biomarkers Prev., 4 (1995)
85. — 28. KAI]-RAK, A., K. ANTONI], K. CAPAK,
R. @IVKOVI], B. KAI], E. MESARO[, Regionalne
razlike u na~inu prehrane i u~estalosti malignih neo-
218
G. @ivanovi}-Posilovi} et al.: Dermatoglyphs and Gastric Cancer, Coll. Antropol. 27 (2003) 1: 213–219
TABLE 4
THE RESULTS OF DISCRIMINANT CLASSIFICATION BETWEEN THE GROUP OF PATIENTS
SUFFERING FROM GASTRIC CANCER AND HEALTHY CONTROL MALES AND FEMALES
Males N Correctlyclassified %
Incorrectly
classified %
Patients 36 26 74.3 9 25.7
Healthy controls 50 39 78.0 11 22.0
Total of correctly classified 76.5
Females N Correctlyclassified %
Incorrectly
classified %
Patients 32 25 78.1 9 21.9
Healthy controls 50 38 76.0 12 24.0
Total of correctly classified 76.8
plazmi u Hrvatskoj. In: Proceedings. (Prehrana i rak,
Zagreb, 1995.). — 29. – JI, B. T., H. W. CHOW, G.
YANG, J. K. MCLAUGHLIN, R. N. GAO, W. ZHENG,
X. O. SHOU, J. F. FRAUMENTI, J. T. GAO, Cancer,
77 (1996) 2449. — 30. XU, G. P., P. J. SONG, P. I.
REED, Eur. J. Cancer Prev., 2 (1993) 327. — 31.
SING, V. N., S. K. GABY, Am. J. Clin. Nutr., 53 (1991)
386. — 32. MEINING, A. G., E. BAYERDORFER, M.
STOLTE, Eur. J. Gastroenterol. Hepatol., 11 (1999)
717. — 33. FORMAN, D., B. GOODMANK, B. M. J.,
320 (2000) 1682. — 34. BLANKFIELD, R. P., A. ZUL-
LO, C. HASSAN, S. MORINI, R. EID, S. F. MOSS, N.
UEMURA, N. Engl. J. Med., 346 (2002) 65. — 35.
CUMMINS, H., C. MIDLO: Fingerprints, palms and
soles. (Dover Publications, New York, 1961). — 36.
SCHAUMANN, B., M. ALTER: Dermatoglyphics in
medical disorders. (Springer-Verlag, New York,
1976). — 37. BABLER,W. J., Birth Defects: Original
Article Series, 27 (1991) 95. — 38. MILI^I], J., P.
RUDAN, LJ. SCHMUTZER, I. [KRINJARI]: Der-
matoglifi u antropolo{kim istra`ivanjima, Praktikum
biolo{ke antropologije. (Antropolo{ka biblioteka, Za-
greb, 1989). – 39. BASAURI, L. A., L. BARNEO, J.
CARNELLA, Oncology, 32 (1975) 27. – 40. RUDAN,
P., Z. PI[L, B. BA[EK, I. [KRINJARI], F. BUDI-
MAN, P. NOLA, N. RUDAN, Z. MARI^I], I. PRO-
DAN, Acta Med. Iug., 35 (1980) 5. – 41. MILI^I], J.,
R. PAVI]EVI], M. HALBAUER, B. [AR^EVI],
Analysis of qualitative dermatoglyphic traits of the
digito-palmar complex in carcinomas. In: DURHAM,
N. M., K. M. FOX, C. C. PLATO (Eds.): The state of
dermatoglyphics, The science of finger and palm
prints. (The Edwin Mallen Press, Lewiston, 2000).
42. MILI^I], J., R. PAVI]EVI], Int. J. Anthropol.,
13 (1998) 24.
G. @ivanovi}-Posilovi}
Anesthesiology Department, General Hospital »Dr. Ivo Pedi{i}«, J.J. Strossmayera 59,
44000 Sisak, Croatia
DERMATOGLIFI I KARCINOM @ELUCA
S A @ E T A K
Karcinom `eluca je vrlo ~esta maligna bolest, ~ija je etiologija jo{ uvijek nepoznata.
Smatra se da nastaje zajedni~kim djelovanjem genetskih ~imbenika i ~imbenika oko-
line. Digito-palmarni dermatoglifi su ve} primjenjivani u procjeni nasljedne osnove ne-
kih malignih bolesti (karcinoma dojke, plu}a, kolorektalnog karcinoma), {to je bio po-
vod za ispitivanje korelacije njihovih kvantitativnih svojstava kod oboljelih od karci-
noma `eluca (36 mu{karaca i 32 `ene) u odnosu na kontrolne skupine fenotipski zdra-
vih osoba (50 mu{karaca i 50 `ena). U~injenom statisti~kom obradom multivarijatnom
i univarijatnom analizom varijance, te diskriminacijskom analizom dokazano je da se
uspore|ivane skupine zna~ajno razlikuju. Potvr|eno je postojanje ve}e u~estalosti
raka `eluca u bolesnika s krvnom grupom A. Iz dobivenih nalaza mogu}e je zaklju~iti
da rezultati kvantitativne analize digito-palmarnih dermatoglifa kod oboljelih od kar-
cinoma `eluca potvr|uju postojanje genetske predispozicije za razvoj ove bolesti.
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